3 Results for "

MOLM-16 AML cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "MOLM-16 AML cells" in MCE Product Catalog:

Cat. No.: HY-155066
CAS No.: 2641899-38-7
Purity:  99.45%
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 arrests HL-60 cell cycle at G1 phase and increases apoptosis. FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research .
loading...
    loading...
Cat. No.: HY-155529
CAS No.: 1422456-47-0
Target:  

Pim

Research Areas:  

Cancer

FD1024 is PIM inhibitor (IC50s: 1.96, 38.9, 4.17 nM for PIM1, 2, 3). FD1024 can be used for research of acute myeloid leukemia. FD1024 has strong antiproliferative activity against the tested AML cell lines, with 0.16 μM, 0.12 μM, 1.05 μM, 1.39μM for EOL-1, MV-4-11, KG-1, MOLM-16 cells. FD1024 also has antitumor efficacy in mice .
loading...
    loading...
Cat. No.: HY-181959
CAS No.: 2752441-61-3
Research Areas:  

Cancer

APL-4098 is an orally active, selective, ATP-competitive GCN2 inhibitor with a Ki of 4.39 nM and a Kd of 2.9 nM. APL-4098 reduces the phosphorylation level of eIF2α and the expression level of ATF4. APL-4098 impairs mitochondrial function and exerts cytotoxic effects on primary acute myeloid leukemia cells. APL-4098 is applicable to research related to acute myeloid leukemia .
loading...
    loading...